Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
34,558
datasets available to search
ShareScore release 0.9.0
Dataset results
34,558 results for “therapy”
Supplementary file 7 for the Cochrane review Psychological therapies for people with borderline personality disorder
<p>A Trial Sequential Analysis figure</p>
Supplementary file 8 for the Cochrane review Psychological therapies for people with borderline personality disorder
<p>A Trial Sequential Analysis figure</p>
Supplementary file 25 for the Cochrane review Psychological therapies for people with borderline personality disorder
<p>A Trial Sequential Analysis figure</p>
Supplementary file 11 for the Cochrane review Psychological therapies for people with borderline personality disorder
<p>A Trial Sequential Analysis figure</p>
Enhancing Collaborative Care in Schizophrenia: A Comparative Analysis of ICF Core Sets Assessments by Occupational Therapy and Mental Health Social Work Students
<p>This repository contains the R code, dataset, and README file for the network analysis of ICF (International Classification of Functioning, Disability, and Health) assessments. The study compares the assessments conducted by occupational therapy students and mental health social work students, analyzing centrality measures and Bridge Expected Influence within their respective networks.</p>
Datasets corresponding to "Direct evaluation of antiplatelet therapy in coronary artery disease by comprehensive image-based profiling of circulating platelets"
<p><strong>Datasets corresponding to "Direct evaluation of antiplatelet therapy in coronary artery disease by comprehensive image-based profiling of circulating platelets"</strong></p> <p><strong>02_CNN_PhenotypeClassif.7z</strong></p> <p>CNN Phenotype classification. Model was trained using AIDeveloper. using manually labelled data. Labelled Data is contained in folder "03_GatedData". The AIDeveloper session file in "02_Model\M10_Nitta6l_32pix_8class_meta.xlsx" shows, which files correspond to which subpopulation. The final model "M10_Nitta6l_32pix_8class_448.model" and corresponding .pb files are also located in that folder.</p> <p><strong>codeforclassification.zip</strong></p> <p>Code for applying model on unlabelled data. Test data is contained in 'sampledata.zip'</p> <p> </p> <p> </p> <p> </p>
Evaluating the Impact of Triple Compound Therapy on Relapse Frequency and Quality of Life in Children with Severe Atopic Dermatitis: A Phase II Randomised Clinical Trial
<p>Datasets and analysis from A multi-centre, randomized controlled trial, on pediatric Atopic Dermatitis, conducted at Red Cross and Walter Sisulu Hospitals. The study is entitled Evaluating the Impact of Triple Compound Therapy on Relapse Frequency and Quality of Life in Children with Severe Atopic Dermatitis: A Phase II Randomised Clinical Trial.</p>
HINC dataset from: Homeopathic treatment as an add-on therapy may improve quality of life and prolong survival in patients with non-small cell lung cancer: A prospective, randomized, placebo-controlled, double-blind, three-arm, multicenter study
<p class="CxSpFirst"><b>Background:</b> Patients with advanced non-small cell lung cancer (NSCLC) have limited treatment options. Alongside conventional anticancer treatment, additive homeopathy might help to alleviate side effects of conventional therapy. The aim of the present study was to investigate whether additive homeopathy might influence quality of life (QoL) and survival in NSCLC patients.</p> <p class="CxSpMiddle"><b>Methods:</b> In this prospective, randomized, placebo-controlled, double-blind, three-arm, multicenter, phase III study, we evaluated the possible effects of additive homeopathic treatment compared with placebo in NSCLC stage IV patients with respect to QoL in the two randomized groups and survival time in all three groups. Treated patients visited the outpatients' centers every 9 weeks. 150 Patients with stage IV NSCLC were included in the study. 98 received either individualized homeopathic remedies (n=51) or placebo (n=47) in a double-blinded fashion. 52 control patients without any homeopathic treatment were observed for survival only. The constituents of the different homeopathic remedies were mainly of plant, mineral or animal origin. The remedies were manufactured by stepwise dilution and succussion, thereby preparing stable Good Manufacturing Practice grade formulations.</p> <p class="CxSpMiddle"><b>Results:</b> QoL as well as functional and symptom scales showed significant improvement in the homeopathy group when compared with placebo after 9 and 18 weeks of homeopathic treatment (p<0.001). Median survival time was significantly longer in the homeopathy group (435 days) vs placebo (257 days; p=0.010) as well as vs control (228 days; p<0.001). Survival rate in the homeopathy group differed significantly from placebo (p=0.020) and from control (p<0.001).</p> <p class="CxSpMiddle"><b>Conclusion:</b> QoL improved significantly in the homeopathy group compared with placebo. In addition, survival was significantly longer in the homeopathy group versus placebo and control. A higher QoL might have contributed to the prolonged survival. The study suggests that homeopathy positively influences not only QoL but also survival. Further studies including other tumor entities are warranted.</p>
Brain Photomodulation Therapy Figures
<p>Those are the figures of the manuscript titled "iA low-cost brain disorders treatment using Near-infrared."</p>
Raw Data for the article: Continuous Renal Replacement Therapy after Liver Transplantation: Peri-Operative Associated Factors and Impact on Survival
<p>Continuous renal replacement therapy (CRRT) following orthotopic liver transplantation (OLT) is usually started for multifactorial reasons, with variable incidence among series. This paper presents a single-center retrospective observational study on the early use (within one week) of CRRT after consecutive cadaveric OLT from January 2008 to December 2016. Preoperative patient characteristics and intraoperative data were collected, and patients were divided into two groups (CRRT and no CRRT) to explore the factors associated with the use of CRRT. Repeated measurements of postoperative creatinine were analyzed with generalized estimating equation (GEE) models. Among 528 OLT patients, 75 (14.2%) were treated with CRRT at least once in the first week. Patients treated with CRRT showed lower survival in a Kaplan-Meier curve (log-rank <em>p</em> value &lt; 0.01). Patients treated with CRRT had a more severe preoperative profile, with a significantly higher age, MELD, BUN, creatinine, and total bilirubin, as well as a longer surgery time and a higher number of transfusions of red blood cells, plasma, and platelets (all <em>p</em> values &lt; 0.05). In a stepwise multiple analysis, the following characteristics remained independently associated with the use of CRRT: the MELD score OR 1.12 (95% CL: 1.07-1.16), <em>p</em> value &lt; 0.001, and the preoperative value for blood urea nitrogen OR 1.016 (95% CL: 1.010-1.023), <em>p</em> value &lt; 0.001. The early use of CRRT after OLT occurred at a low rate in this large cohort; however, it was associated with worse outcomes. Apart from the preoperative severity, repeated intraoperative hypotension episodes, which were likely modifiable or preventable, were associated with the increased use of CRRT and higher postoperative creatinine.</p>
Laser Beam Characterization Data Related to Testing Different Near-Infrared Laser Therapy Devices Used in Sports Medicine
<p>This dataset contains laser beam characterization data collected for different near-infrared laser therapy devices that are used in sports medicine. Data were collected between September 2021 and December 2022 at the Department of Anatomy II (Neuroanatomy) of the Ludwig-Maximilians University of Munich, Germany. Laser therapy devices were characterized using a thermal power sensor, a photodiode, and a beam profiling camera (for details, see [1]). Two different laser therapy devices were investigated (Dolorclast High Power Laser, Electro Medical Systems; Cube 4 Med, Eltech K-laser s.r.l.). The measurements were repeated for three units of each laser therapy device (EMS-1, EMS-2, EMS3; K-1, K-2, K-3). The dataset contains raw data files from each sensor that include text (TXT) files, comma-separated-values (CSV) formatted files, and raw camera recordings in binary format (BINARY.BGDATA). The data was used to create figures that were submitted to the journal MDPI Biomedicines [1]. The figures in [1] were created with Python in a Jupyter Notebook, which is also included in this dataset.</p> <p><strong>2023-02-17 Update: The manuscirpt has been published in MDPI Biomedicines [2]. If you make any use of this dataset, please cite [2].</strong></p> <p>[1] Kaub, L.; Schmitz, C. Spread of the Optical Power Emission of Several Units of the Same Laser Therapy Devices Used in Sports Medicine, Which Cannot Be Assessed by the Users, Shown by Means of High-Fidelity Laser Measurement Technology. <em>Preprints</em> <strong>2023</strong>, <em>2023010251</em>, https://doi.org/10.20944/preprints202301.0251.v1.</p> <p>[2] Kaub, L.; Schmitz, C. Spread of the Optical Power Emission of Three Units Each of Two Different Laser Therapy Devices Used in Sports Medicine, Which Cannot Be Assessed by the Users, Shown by Means of High-Fidelity Laser Measurement Technology. <em>Biomedicines</em> <strong>2023</strong>, <em>11</em>, 585. https://doi.org/10.3390/biomedicines11020585</p>
Long-read sequencing of diagnosis and post-therapy medulloblastoma reveals complex rearrangement patterns and epigenetic signatures
<p>Imaging data related to the "Long-read sequencing of diagnosis and post-therapy medulloblastoma reveals complex rearrangement patterns and epigenetic signatures" manuscript</p>
Microhardness for SDF group after Radiation Therapy
<p>The table shows microhardness values of 11 samples of SDF group after Radiation Therapy. Each microhardness value was determined by assessing 5 different sites on the enamel surface and the final SMH was noted.</p> <p>The microhardness for the SDF group ranged from 214.5-309.9 HV.</p> <p> </p>
Microhardness of control group teeth after Radiation Therapy
<p>The table shows microhardness values of 11 samples of control group after Radiation Therapy. Each microhardness value was determined by assessing 5 different sites on the enamel surface and the final SMH was noted.The microhardness values for the control group ranged from 70.68 - 93.44 HV.</p>
Adapting Clinical Practice Guidelines for Chronic Kidney Disease: Blood Pressure Management and Kidney Replacement Therapy in Adults and Children in the Saudi Arabian context using the GRADE-ADOLOPMENT methodology
<p>This compressed ZIP file includes three components</p> <p>The Full Guideline Document (FINAL COPY) for the <strong>2022 Saudi Guideline for Chronic Kidney Disease: Blood Pressure Management and Kidney Replacement Therapy in Adults and Children</strong></p> <p>In addition to two guideline reporting checklists to ensure the quality of this adoloped guideline:-</p> <p><strong>1- AGREE Reporting Checklist</strong></p> <p><strong>2- RIGHT-Ad@pt Checklist</strong></p> <p>As a supplementary to the submitted article entitled:_</p> <p><strong>Adapting Clinical Practice Guidelines for Chronic Kidney Disease: Blood Pressure Management and Kidney Replacement Therapy in Adults and Children in the Saudi Arabian context using the GRADE-ADOLOPMENT methodology</strong></p>
Comparative evaluation of the forces produced by tongue on circummaxillary sutures in skeletal Class III malocclusion with maxillary hypoplasia using tongue crib with that of facemask therapy - A FEM study
<p>Data sheet showing stimulation result</p>
Post COVID-19 trends in simulation use within diagnostic radiography and radiation therapy education.
<p>The authors developed and deployed an online survey among diagnostic radiography and/or radiation therapy educators with experience in pre-registration training (academic, clinical or combined).The aim of this study was to capture global trends and activity on simulation-based education (SBE) in medical imaging and radiation therapy education. Simulation is a well-established component of medical radiation science training that embraces a wide range of activities and resources all aiming to provide a safe environment in which to practice clinical skills. The survey instrument design was informed by a prior review of the literature, a previous international survey conducted by members of the research team<sup>1</sup> and experience within the research team. It comprised two open and 27 closed questions designed to ascertain data across four domains: type of training environment of the respondent (n=13), access to and use of simulation within the participants’ institution (n=13) and possible future trends in simulation (n=3). Data captured in this study was compared with similar data from Bridge and colleagues previous survey in 2020.<sup>1 </sup>There is an opportunity for this dataset to add to the evidence base on the evolving landscape of the use of SBE in radiography/radiation therapy education. Such information has the potential to inform future practices and to create best-practice standards in the adoption of simulation-based educational resources and activities in diagnostic radiography and radiation therapy.</p> <p>Reference:</p> <ol> <li>Bridge P, Shiner N, Bolderston A, et al. International audit of simulation use in pre-registration medical radiation science training. <em>Radiography (Lond)</em>. Nov 2021;27(4):1172-1178. doi:10.1016/j.radi.2021.06.011</li> </ol>
Positive p53 expression is significantly found higher in luminal B HER-2 negative cases with primary endocrine therapy resistance: A multicenter retrospective cross-sectional study in Indonesia
<p><strong>Positive p53 expression is significantly found higher in luminal B HER-2 negative cases with primary endocrine therapy resistance: A multicenter retrospective cross-sectional study in Indonesia</strong></p>
Underlying qualitative data for: "What went wrong? A qualitative exploration of the determinants of poor antiretroviral therapy adherence and retention in care among pregnant and postpartum women in the Uganda WiseMama randomized controlled trial"
<p>This dataset is the underlying qualitative data for the paper entitled: "What went wrong? A qualitative exploration of the determinants of poor antiretroviral therapy adherence and retention in care among pregnant and postpartum women in the Uganda WiseMama randomized controlled trial"</p>
Analysis on CD8+/FOXP3+Ratio and Its Association with Primary Endocrine Therapy Resistance in Indonesian Luminal B Her-2 Negative BC Patients
<p>Analysis on CD8+/FOXP3+Ratio and Its Association with Primary Endocrine Therapy Resistance in Indonesian Luminal B Her-2 Negative BC Patients</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.